Altered kynurenine pathway metabolism and association with disease activity in patients with systemic lupus
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Altered kynurenine pathway metabolism and association with disease activity in patients with systemic lupus
Authors
Keywords
-
Journal
AMINO ACIDS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-05
DOI
10.1007/s00726-023-03353-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Complement as a Biomarker for Systemic Lupus Erythematosus
- (2023) Masahiro Ayano et al. Biomolecules
- Kynurenine Pathway Metabolites as Potential Biomarkers in Chronic Pain
- (2023) Andrew Auyeung et al. Pharmaceuticals
- Role of interleukin-6 and interferon-α in systemic lupus erythematosus: A case–control study and meta-analysis
- (2022) Sarit Sekhar Pattanaik et al. LUPUS
- Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders – Advances and challenges
- (2022) Tapas Kumar Goswami et al. Human Vaccines & Immunotherapeutics
- IFN-γ, should not be ignored in SLE
- (2022) Wenping Liu et al. Frontiers in Immunology
- AHR/TET2/NT5E axis downregulation is associated with the risk of systemic lupus erythematosus and its progression
- (2022) He‐Hsiung Cheng et al. IMMUNOLOGY
- Dynamic changes in kynurenine pathway metabolites in multiple sclerosis: A systematic review
- (2022) Mobina Fathi et al. Frontiers in Immunology
- Associations between circulating interferon and kynurenine/tryptophan pathway metabolites: support for a novel potential mechanism for cognitive dysfunction in SLE
- (2022) Erik W Anderson et al. Lupus Science & Medicine
- Correlation of Indoleamine-2,3-Dioxygenase and Chronic Kidney Disease: A Pilot Study
- (2021) Binbin Pan et al. Journal of Immunology Research
- Quinolinic acid is associated with cognitive deficits in schizophrenia but not major depressive disorder
- (2021) Flurin Cathomas et al. Scientific Reports
- Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy
- (2021) Amrita Basu et al. Frontiers in Immunology
- Frequency of Systemic Lupus Erythematosus Was Decreasing Among Hospitalized Patients From 2013 to 2017 in a National Database in China
- (2021) Ying Tan et al. Frontiers in Medicine
- The Kynurenine Pathway—New Linkage between Innate and Adaptive Immunity in Autoimmune Endocrinopathies
- (2021) Anna Krupa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tryptophan-kynurenine metabolism: a link between the gut and brain for depression in inflammatory bowel disease
- (2021) Li-Ming Chen et al. Journal of Neuroinflammation
- The kynurenine pathway in chronic diseases: a compensatory mechanism or a driving force?
- (2021) Niklas Joisten et al. TRENDS IN MOLECULAR MEDICINE
- Complement C4, Infections, and Autoimmune Diseases
- (2021) Hongbin Wang et al. Frontiers in Immunology
- Clinical and Immunological Biomarkers for Systemic Lupus Erythematosus
- (2021) Haitao Yu et al. Biomolecules
- The Kynurenine Pathway as a Potential Target for Neuropathic Pain Therapy Design: From Basic Research to Clinical Perspectives
- (2021) Katarzyna Ciapała et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Identification of Peptides as Novel Inhibitors to Target IFN-γ, IL-3, and TNF-α in Systemic Lupus Erythematosus
- (2021) Ghulam Mustafa et al. Biomed Research International
- Serum Metabolic Profiles of the Tryptophan-Kynurenine Pathway in the high risk subjects of major depressive disorder
- (2020) Masashi Sakurai et al. Scientific Reports
- Kynurenine Pathway of Tryptophan Metabolism in Neuropsychiatric Disorders: Pathophysiologic and Therapeutic Considerations
- (2020) Ather Muneer Clinical Psychopharmacology and Neuroscience
- The Aryl Hydrocarbon Receptor in Chronic Kidney Disease: Friend or Foe?
- (2020) Yenan Mo et al. Frontiers in Cell and Developmental Biology
- Immunological pathogenesis and treatment of systemic lupus erythematosus
- (2019) Lu Pan et al. World Journal of Pediatrics
- High phthalate exposure increased urinary concentrations of quinolinic acid, implicated in the pathogenesis of neurological disorders: Is this a potential missing link?
- (2019) Feiby L. Nassan et al. ENVIRONMENTAL RESEARCH
- AhR Activation by TCDD (2,3,7,8-Tetrachlorodibenzo-p-dioxin) Attenuates Pertussis Toxin-Induced Inflammatory Responses by Differential Regulation of Tregs and Th17 Cells Through Specific Targeting by microRNA
- (2019) Zinah Zamil Al-Ghezi et al. Frontiers in Microbiology
- Increased urinary excretion of kynurenic acid is associated with non-recovery from acute kidney injury in critically ill patients
- (2018) Fabienne Aregger et al. BMC Nephrology
- Kynurenine, a Tryptophan Metabolite That Accumulates With Age, Induces Bone Loss
- (2017) Mona El Refaey et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies
- (2017) Frances Rees et al. RHEUMATOLOGY
- Elevated Levels of Peripheral Kynurenine Decrease Bone Strength in Rats with Chronic Kidney Disease
- (2017) Bartlomiej Kalaska et al. Frontiers in Physiology
- Beta-trace Protein as a new non-invasive immunological Marker for Quinolinic Acid-induced impaired Blood-Brain Barrier Integrity
- (2017) Andreas Baranyi et al. Scientific Reports
- Aryl Hydrocarbon Receptor Deficiency Attenuates Oxidative Stress-Related Mesangial Cell Activation and Macrophage Infiltration and Extracellular Matrix Accumulation in Diabetic Nephropathy
- (2016) Wen-Jane Lee et al. ANTIOXIDANTS & REDOX SIGNALING
- Systemic lupus erythematosus
- (2016) Arvind Kaul et al. Nature Reviews Disease Primers
- Tryptophan-kynurenine pathway is dysregulated in inflammation and immune activation
- (2015) Ming-Hui Zou Frontiers in Bioscience-Landmark
- Increased Plasma Levels of Xanthurenic and Kynurenic Acids in Type 2 Diabetes
- (2015) Gregory F. Oxenkrug MOLECULAR NEUROBIOLOGY
- Aryl Hydrocarbon Receptors in Osteoclast Lineage Cells Are a Negative Regulator of Bone Mass
- (2015) Tai-yong Yu et al. PLoS One
- Complement C4 induces regulatory T cells differentiation through dendritic cell in systemic lupus erythematosus
- (2015) Hong-Bin Cheng et al. Cell and Bioscience
- Pathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus Erythematosus
- (2015) Timothy A. Gottschalk et al. Frontiers in Immunology
- Interferon (IFN)-γ-mediated inflammation and the kynurenine pathway in relation to bone mineral density: the Hordaland Health Study
- (2014) E. M. Apalset et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Suppression of Th1 cytokine production by a peptide derived from C4b
- (2013) Yuji Takeda et al. INFLAMMATION RESEARCH
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
- (2012) Michelle Petri et al. ARTHRITIS AND RHEUMATISM
- The role of Tumor Necrosis Factor-alpha (TNF-α) in the pathogenesis of systemic lupus erythematosus
- (2011) Mariana Postal et al. CYTOKINE
- Interferon Alpha in Systemic Lupus Erythematosus
- (2010) Timothy B. Niewold et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started